Last reviewed · How we verify
LY3848575
At a glance
| Generic name | LY3848575 |
|---|---|
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy (PHASE2)
- A Study of LY3848575 in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |